View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.WebsiteVideoWhat do you #DiscoverCareBelieve?
A new laboratory test predicts which of several cancer drugs will work best against a patient's tumor, and could become a powerful precision medicine tool for individualizing cancer therapy.
New patients with cancer can now make an appointment to see an oncologist as soon as the following day at Dana-Farber/Brigham and Women's Cancer Center.
Dana-Farber experts share five things you should know about precision medicine.
A study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug olaparib is potentially much wider — and offers a ready means of identifying them.
Dr. Lawrence Shulman wrote about his work in Rwanda and providing access to life-saving advances in cancer treatment through the collaborations of the Rwandan Ministry of Health, Partners in Health, and Dana-Farber.
Dr. Anthony Letai led a study showing a new technique that can predict which specific drug will be most effective in treating various types of cancer tumors.
Dr. Paul Richardson commented on the US Food and Drug Administration’s decision to expand the existing indication for lenalidomide (Revlimid) in combination with dexamethasone to include patients with newly diagnosed multiple myeloma.
Dana-Farber physicians including Dr. Barrett Rollins and Dr. Kenneth C. Anderson talked about the next generation of cancer-fighting drugs at the 14th annual Breakfast with the Doctors in Palm Beach.
Dr. Steven Treon discussed the game-changing discoveries in Waldenström’s Macroglobulinemia that led to the approval of ibrutinib for treatment of the disease
Drs. Joanne Wolfe, Janet Abrahm, and Susan Block, members of the Pediatric Advanced Care Team - or PACT - at Dana Farber/Boston Children’s Cancer and Blood Disorders Center, commented on the challenges of pediatric palliative care.
Dr. Joanne Wolfe, director of the Pediatric Advanced Care Team, or PACT, at Dana Farber/Boston Children’s Cancer and Blood Disorders Center, commented on the challenges of pediatric palliative care.
Sarcoma Support Group
12:30 PM - 1:30 PM
Smith Building, Room 330
This groups comes together with the purpose of providing mutual support and education for sarcoma patients and their loved ones. The group serves to foster connection between patients in order to decrease feelings of isolation.
Registration is required. Please register by calling Larissa Hewitt at 617-582-7548.
Sarcoma Support Group for Patients and Family Members
This group is an opportunity to share information, coping skills, and network with others with Sarcoma and their caregivers.Facilitated by: Larissa Hewitt, LICSW**Dial in options are available if you cannot attend in person
Registration required: Call Larissa Hewitt: 617-582-7548Parking will be validated in the Dana-Farber Yawkey Garage
Look Good...Feel Better - Weymouth(3)
2:00 PM - 4:00 PM
1st Fl. Conf. Room - 101 Columbian Street, South Weymouth, MA 02190
An American Cancer Society sponsored program for women. Come have fun while you learn beauty tips to help you look and feel better while you are in treatment.
Patient referral information, clinical resources and more.
For adults:877-442-3324Quick access: Appointments as soon as the next day for new adult patientsFor children:888-733-4662Or complete the online form.
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
Top-ranked cancer center in New England for adults — #1 in the nation for children's cancer
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: